A study conducted by IISc and Leiden University reveals a disconnect between India's health research publications and DALYs.

Disability Adjusted Life Years (DALYs) serve as a measure of a population's health.

The results of the study highlight the gross disparity, with certain diseases receiving more research attention than their actual burden.

Diabetes mellitus, with a 3.1% DALY contribution, garnered 7.5% of the research focus.

Neonatal conditions, with a 12.3% DALY share, received only 1.3% of research attention.

Similarly, cancer and cardiovascular diseases, despite their significant contribution to India's disease burden, have received less attention from the research fraternity.

Tuberculosis (TB) serves as a well-aligned example, with India dedicating research efforts proportionate to its 7% disease burden.

Figures reveal India's research focuses on diseases with lower domestic impact but substantial global threats, such as malaria and HIV/AIDS.

Global research priorities often cater to the demands of high-income countries, resulting in funding mismatches in the global south.